ANH News Beat (22/2026)

ANH NewsBeat Generic Image
Our weekly roundup of the latest natural news from across the globe in one place. This week: Save our Supplements campaign; Complementary therapies go mainstream; Biofield therapy & cancer; Challenging GMOs & fluoridation; Updates from ANH-USA; Free Speech Threats and much more...

In this article

In Brief (click on the links to read more)

Natural News

  • The EU is finally set to slash the maximum permitted levels (MPLs) of nutrients in dietary supplements—threatening to wipe many popular high-strength products from shelves altogether. Having been at the forefront of this campaign when it first raised its head in 2007, it’s imperative to understand that under the guise of “harmonisation” and consumer protection, essential supplements used daily by millions for immune health, energy, stress support and healthy ageing for example, would have to be reformulated into little more than nutritional window dressing. Such a change will also affect British consumers as the current government imports EU legislation lock stock and barrel. This goes far beyond vitamins. It’s about health freedom, consumer choice, and the right of individuals and practitioners to access nutritional support tailored to real-world needs — not arbitrary bureaucratic limits. At a time when chronic illness is soaring and healthcare systems are struggling, restricting access to safe, therapeutic-level supplements risks pushing Europe even further away from genuinely preventive healthcare. If you live in the EU or care about supplement freedom, now is the time to act – before it’s too late: visit saveoursupplements.ie to add your voice.
  • France has launched a sweeping crackdown on CBD edibles, ordering the removal of food products containing cannabidiol (CBD) from the market on the grounds that their safety has not been proven under EU Novel Foods rules. The move targets CBD gummies, supplements, drinks, oils and other ingestible products, with French authorities also warning consumers not to buy or consume them as enforcement activity intensifies. For natural health advocates, the decision raises wider concerns about the growing use of precautionary regulation to restrict access to low-risk natural products despite widespread consumer demand and years of commercial use. ANH has long warned that increasingly rigid interpretations of EU safety frameworks risk creating a chilling effect across the broader supplement and wellness sector, particularly where regulators demand impossible levels of evidence for products with well-established histories of use.
  • A new randomised clinical trial published in JAMA Network Open suggests higher-dose vitamin D supplementation during pregnancy may have long-term cognitive benefits for children. Researchers found that children whose mothers took 2,800 IU of vitamin D3 daily during the second half of pregnancy performed better on verbal and visual memory tests at age 10 compared to children whose mothers received the standard 400 IU dose. While the study did not find improvements in overall IQ or attention, the findings add to growing evidence linking prenatal nutrition with neurodevelopmental outcomes. For integrative and functional medicine practitioners, the research underscores the importance of optimising maternal nutrient status during pregnancy as part of a broader preventive health strategy.
  • A new preclinical study published in Cancer Medicine is adding to the growing body of evidence that biofield therapy deserves serious scientific attention. Researchers found significant reductions in pancreatic cancer cell proliferation across multiple cell lines following biofield therapy exposure, with treated cells showing disrupted mitochondrial energy processes—suggesting a plausible biological mechanism. The study included sham controls and also examined effects on tumour invasion and metastasis in live mouse models. The study gives a compelling signal that the body’s biofield is an emerging scientific frontier conventional medicine can no longer afford to ignore.
  • Complementary and natural health approaches are firmly mainstream according to a recent study published in the American Journal of Medicine. Surveying over 16,000 older adults, researchers found that nearly 59% had used at least one complementary therapy in the past year and more than 76% had done so at some point in their lives—with spiritual practices, manual therapies such as chiropractic care and herbal products among the most popular. Crucially, these choices are often made without any discussion with a conventional healthcare provider. The study brings further evidence that integrative and natural health approaches are not fringe interests but a fundamental part of how people manage their wellbeing, and why protecting access to them matters more than ever.
  • A landmark Veteran (VA) clinical trial, published in JAMA, involving 764 US veterans with chronic pain, found that an interdisciplinary “Whole Health” approach significantly outperformed both cognitive behavioural therapy (CBT) and standard care in reducing the impact of pain on daily life. The model combined primary care with integrative therapies such as acupuncture, chiropractic care, physical therapy and wellness coaching, while also increasing patient engagement with non-drug therapies. The findings add to a growing body of evidence supporting whole-person, non-pharmacologic approaches (including supplements) to chronic pain management and opioid reduction. Researchers say the study could help shape future VA pain management guidelines and broader implementation of integrative care models across healthcare systems.
  • Campaigners across Europe are urging citizens to contact their MEPs (Members of the European Parliament)—here or here — over plans to deregulate new genetically engineered (gene-edited) crops and foods. Before a vote on June 17. Campaigners warn that the proposed changes could remove key safeguards such as traceability, labelling and risk assessments for many gene-edited organisms, making it harder for consumers and farmers to know what’s entering the food chain. At stake are transparency, consumer choice, environmental protection and the public’s right to informed consent about the technologies used in food production, removing the ability of consumers to avoid gene-edited foods altogether—a precedent that could further weaken democratic oversight of the food system in favour of industry interests.
  • In the UK, Beyond GM’s landmark judicial review of the UK Government’s gene-editing deregulation reached the High Court this month, with the two-day hearing laying bare some striking contradictions in the government’s position. Government barristers conceded that precision bred organisms (PBOs) are scientifically GMOs while arguing they shouldn’t be regulated as such; claimed PBOs are safe and equivalent to conventional crops while acknowledging unique environmental risks; and suggested consumers who want to avoid GMOs should simply eat organic — while defending the removal of the very traceability tools that allow organic farmers to stay GMO-free. The judge engaged seriously with both sides and a ruling is now awaited. But as Beyond GM note, whatever the outcome, this case has already shifted the conversation — forcing government movement on issues like mandatory PBO seed labelling that it would rather have left unresolved.
  • A US appeals court has sent Fluoride Action Network’s ongoing fluoridation lawsuit back to a lower court for reconsideration, ruling on a procedural technicality that the original judge overstepped his remit by pausing the case in 2020 to await a major government report on fluoride’s effects on brain development. Crucially, the appeals court did not overturn the lower court’s earlier finding that water fluoridation poses an unreasonable risk to health—nor did it side with the EPA’s push to reverse that ruling outright. FAN says the case is still ongoing and remains optimistic that the underlying scientific evidence supporting its claims remains strong.

ANH-USA Update

  • A new Bill introduced to the US Congress would prevent the US Food and Drug Administration (FDA) from reclassifying natural desiccated thyroid (NDT) as a biologic thus protecting patient access to it. The Protecting Equal Access to Thyroid (PEAT) Act of 2026 would protect patients access to NDT and compounded NDT – a lifeline for those who rely on it. Action Alert! Protect compounded NDT.
  • A familiar playbook has been opened in the US. Use a few cases of contamination in a natural health product to justify banning entire categories. Following on from homeopathy and supplements, the latest target are peptides. It’s not the existence of peptides that’s the issue it’s the bad actors selling contaminated products. Donate to support ANH-USA’s work to protect access to natural health options in the US.

Free Speech Updates

  • Convicted for telling the truth. When giving a university lecture linking mass migration to a deterioration in the quality of life in Belgium, Dries Van Langenhove, evidenced his argument using statistics and scientific sources. This made no difference as a judge convicted Van Langenhove for hate speech as he was “…presenting facts in a way that incites hatred against persons…”. The most chilling aspect of this, is that the judge didn’t challenge the scientific accuracy of his arguments. In other words speak out against the narrative and you risk being punished. It’s a sad inditement of the times we now live in where presenting a scientifically supported argument can cost you your freedom.
  • Patrick Wood visualises the very playbook being used to silence dissent in a powerful new infographic that pulls together the threads of AI-controlled censorship.

Add a Comment

Your email address will not be published. Required fields are marked *


Share:

Related Posts

Alone in a Crowd

The loneliness epidemic

Loneliness and social isolation don’t just break hearts. Find out why social disconnection is a modern day disease epidemic and what we can do about it

ANH NewsBeat Generic Image

ANH News Beat (26/2026)

Our weekly roundup of the latest natural news from across the globe in one place. This week: Big tobacco & UPFs; Regenerative greenwashing; EU deregulates gene-editing; Needles, not pills; Plus updates from ANH-USA and much more…

Tags - Associated Content

Shopping Basket

Contact Us

Contact Form